皮肤穿神经刺激对女性神经干扰器过度活动,性功能障碍和多发性硬化症患者的性功能的影响
Athanasios Zachariou1,2, Ioannis Giannakis1, Aris Kaltsas3
1Department of Urology, Medical School of Ioannina, University General Hospital, 455 00 Ioannina, Greece.
Journal of clinical medicine
|October 26, 2024
概括
皮肤穿神经刺激 (PTNS) 在患有多发性硬化症 (MS) 的女性中显著改善了性功能和过度活跃的膀症状. 这种非侵入性治疗为管理这些常见的MS相关问题提供了有希望的解决方案.
科学领域:
- 神经学 神经学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 性医学性医学性医学性医学
背景情况:
- 多发性硬化症 (MS) 通常会导致尿路和性功能障碍,降低生活质量.
- 对于MS患者的膀问题,标准治疗方法往往是不够的.
- 皮肤穿神经刺激 (PTNS) 是作为一种替代疗法的研究.
研究的目的:
- 评估PTNS在改善性功能和膀症状方面的有效性.
- 评估PTNS对MS患者的女性性功能障碍 (FSD) 和神经元性detrusor过度活动 (NDO) 的影响.
主要方法:
- 65名患有NDO的女性MS患者接受了12周的PTNS.
- 通过FSFI和FSDS-R评估的性功能;通过OAB-v8.8评估的膀症状.
- 结果与20名患者的对照组进行了比较,这些患者的PTNS下降.
主要成果:
- 在女性性功能指数 (FSFI) 的所有领域都观察到显著改善 (p < 0.05).
- 在接受PTNS.的58.46%患者中,过活性膀 (OAB) 症状有所改善.
- 对照组在症状上没有显著的变化.
结论:
- 在患有NDO和FSD的女性MS患者中,PTNS有效增强性功能和尿路症状.
- 这种非侵入性治疗为管理这些复杂的疾病提供了可行的替代方案.
- PTNS为改善MS患者的生活质量提供了一个有前途的治疗选择.
相关概念视频
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...


